205 related articles for article (PubMed ID: 11583639)
1. Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial.
Castro-Guardiola A; Viejo-Rodríguez AL; Soler-Simon S; Armengou-Arxé A; Bisbe-Company V; Peñarroja-Matutano G; Bisbe-Company J; García-Bragado F
Am J Med; 2001 Oct; 111(5):367-74. PubMed ID: 11583639
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
Marras TK; Nopmaneejumruslers C; Chan CK
Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
[TBL] [Abstract][Full Text] [Related]
3. Comparison between the Efficacy of Switch Therapy and Conventional Therapy in Pediatric Community-Acquired Pneumonia.
In-iw S; Winijkul G; Sonjaipanich S; Manaboriboon B
J Med Assoc Thai; 2015 Sep; 98(9):858-63. PubMed ID: 26591395
[TBL] [Abstract][Full Text] [Related]
4. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia.
Ramirez JA; Vargas S; Ritter GW; Brier ME; Wright A; Smith S; Newman D; Burke J; Mushtaq M; Huang A
Arch Intern Med; 1999 Nov; 159(20):2449-54. PubMed ID: 10665893
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy of switch therapy in community-acquired pneumonia in Japan].
Uchiyama N; Aoshima M; Satoh T; Chonabayashi N
Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):261-7. PubMed ID: 12795180
[TBL] [Abstract][Full Text] [Related]
6. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia.
Ramirez JA; Bordon J
Arch Intern Med; 2001 Mar; 161(6):848-50. PubMed ID: 11268227
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
Izadi M; Dadsetan B; Najafi Z; Jafari S; Mazaheri E; Dadras O; Heidari H; SeyedAlinaghi S; Voltarelli F
Recent Pat Antiinfect Drug Discov; 2018; 13(3):228-239. PubMed ID: 30360748
[TBL] [Abstract][Full Text] [Related]
8. Oral or intravenous-to-oral antibiotic switch therapy for treating patients with community-acquired pneumonia.
Cunha BA
Am J Med; 2001 Oct; 111(5):412-3. PubMed ID: 11583649
[No Abstract] [Full Text] [Related]
9. The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy.
Rhew DC; Hackner D; Henderson L; Ellrodt AG; Weingarten SR
Chest; 1998 Jan; 113(1):142-6. PubMed ID: 9440581
[TBL] [Abstract][Full Text] [Related]
10. Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis.
Athanassa Z; Makris G; Dimopoulos G; Falagas ME
Drugs; 2008; 68(17):2469-81. PubMed ID: 19016574
[TBL] [Abstract][Full Text] [Related]
11. Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia.
Erard V; Lamy O; Bochud PY; Bille J; Cometta A; Calandra T
Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):82-8. PubMed ID: 14727149
[TBL] [Abstract][Full Text] [Related]
12. Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis.
Rhew DC; Tu GS; Ofman J; Henning JM; Richards MS; Weingarten SR
Arch Intern Med; 2001 Mar; 161(5):722-7. PubMed ID: 11231705
[TBL] [Abstract][Full Text] [Related]
13. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.
Belforti RK; Lagu T; Haessler S; Lindenauer PK; Pekow PS; Priya A; Zilberberg MD; Skiest D; Higgins TL; Stefan MS; Rothberg MB
Clin Infect Dis; 2016 Jul; 63(1):1-9. PubMed ID: 27048748
[TBL] [Abstract][Full Text] [Related]
14. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P;
Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial.
Oosterheert JJ; Bonten MJ; Schneider MM; Buskens E; Lammers JW; Hustinx WM; Kramer MH; Prins JM; Slee PH; Kaasjager K; Hoepelman AI
BMJ; 2006 Dec; 333(7580):1193. PubMed ID: 17090560
[TBL] [Abstract][Full Text] [Related]
16. [Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy].
Fernández P; San Martín L
Rev Med Chil; 2000 Mar; 128(3):267-72. PubMed ID: 10962867
[TBL] [Abstract][Full Text] [Related]
17. Duration and route of antibiotic therapy in community-acquired pneumonia: switch and step-down therapy.
Cassiere HA; Fein AM
Semin Respir Infect; 1998 Mar; 13(1):36-42. PubMed ID: 9543474
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia.
Stein GE; Mantz SL
Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526
[TBL] [Abstract][Full Text] [Related]
19. Comparison of processes and outcomes of pneumonia care between hospitalists and community-based primary care physicians.
Rifkin WD; Conner D; Silver A; Eichorn A
Mayo Clin Proc; 2002 Oct; 77(10):1053-8. PubMed ID: 12374249
[TBL] [Abstract][Full Text] [Related]
20. Short-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis.
Li Q; Zhou Q; Florez ID; Mathew JL; Shang L; Zhang G; Tian X; Fu Z; Liu E; Luo Z; Chen Y
JAMA Pediatr; 2022 Dec; 176(12):1199-1207. PubMed ID: 36374480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
